semaglutide legal Consumer group presses U.S. to authorize generic GLP-1s FBI warns about counterfeit weight

Biotech Innovation: Companies may rethink patent strategies, focusing on novel formulations or AI-driven R&D to stay ahead of generics

Legitimate compounders will answer right away

For patients taking oral semaglutide (Rybelsus), timing considerations are important

If positive dietary and exercise habits have been established during treatment, long-term maintenance is more achievable

This decision, reported by Fierce Pharma, marks a significant step toward accelerating the market entry of generic semaglutide, potentially reshaping the $18 billion diabetes and obesity treatment market

The Kaiser Permanente Medical Weight Management Program is open to Kaiser members and non-members